Europe — EMA
Tagant (Enzalutamide)
Tagant (Enzalutamide) is an oral prescription medication used for prostate cancer treatment. It belongs to the androgen receptor inhibitors class, helping slow
Request sourcing
What is Enzalutamide?
Tagant (Enzalutamide) is an oral prescription medication used for prostate cancer treatment. It belongs to the androgen receptor inhibitors class, helping slow disease progression. This non-steroidal option is taken once daily with or without food. Always consult a healthcare provider before use.
What is Enzalutamide used for?
Tagant (Enzalutamide) is primarily used to treat prostate cancer in men, particularly in advanced or metastatic cases. It works by blocking the effects of male hormones that can promote cancer growth. This medication is often prescribed when other treatments are no longer effective. Patients may wonder, 'what is Tagant Enzalutamide used for' to understand its role in managing prostate cancer.
What are the side effects of Enzalutamide?
Common effects of Tagant (Enzalutamide) may include fatigue, back pain, or hot flashes. Some users report reduced appetite or weight loss during treatment. These effects vary by individual and should be monitored by a healthcare professional.
What precautions apply to Enzalutamide?
Tagant (Enzalutamide) should be handled with care, especially for those with a history of seizures or heart conditions. It is important to inform your doctor about all medications and supplements being taken. Regular check-ups are recommended to assess treatment progress and manage any side effects.
What does Enzalutamide interact with?
Tagant (Enzalutamide) may interact with blood thinners, certain antibiotics, or medications that affect liver enzymes. Alcohol and grapefruit products could also influence its effectiveness. Always disclose your full medication list to avoid potential interactions.



